SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genaissance Pharmaceuticals (GNSC)
An SI Board Since September 2000
Posts SubjectMarks Bans Symbol
183 6 0 GNSC
Emcee:  Jim Oravetz Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
158Genaissance Pharmaceuticals Signs Two Agreements With the United States Departmenigel bates-10/6/2004
157Genaissance Pharmaceuticals Licenses Compound from Merck KGaA Thursday Septembernigel bates-9/23/2004
156Genaissance Pharmaceuticals Launches its Proprietary FAMILION(TM) Test for Genetnigel bates-5/20/2004
155Genaissance Pharmaceuticals Reports First Quarter Results for 2004 Tuesday May 1nigel bates-5/11/2004
154Genaissance Pharmaceuticals Analyzed Samples for United States Department of Agrnigel bates-1/9/2004
153Genaissance Pharmaceuticals, Inc. to Acquire Lark Technologies, Inc. Friday Decenigel bates-12/19/2003
152Genaissance Pharmaceuticals Enters Into HAP(TM) Technology License Agreement Witnigel bates-12/18/2003
151Genaissance Pharmaceuticals and Ferring Pharmaceuticals Sign Pharmacogenomics Agnigel bates-12/11/2003
150Genaissance Pharmaceuticals and INTEC Web and Genome Informatics Corporation Annnigel bates-12/4/2003
149>>NEW HAVEN, Conn., Nov. 18 /PRNewswire-FirstCall/ -- Genaissance Pharmacetuck-11/18/2003
148>>ORLANDO, Fla., Nov. 11 /PRNewswire-FirstCall/ -- Genaissance Pharmaceutituck-11/11/2003
147Perlegen--a short article in September 1st Fortune magazine. Not much of the arMike McFarland-10/8/2003
146Genaissance Reaches Milestone in CARING Study Wednesday September 17, 7:30 am ETnigel bates-9/17/2003
145United States Patent Application 20030165844 Kind Code A1 Anastasio, Alison Enigel bates-9/11/2003
144Genaissance Pharmaceuticals and AstraZeneca Sign Pharmacogenomics Based Agreemennigel bates-9/11/2003
143Genaissance Pharmaceuticals Announces Scientific Management Changes NEW HAVEN, CJim Oravetz-7/29/2003
142Looks like they just left Bio 2003. Here is an article from that conf. that hasJim Oravetz-6/27/2003
141Today's drop looks wholly artificial. I think something's up. Looks likTom Caruthers-6/26/2003
140Genaissance Pharmaceuticals Expands Licensing Agreement With Prometheus Laboratonigel bates-5/16/2003
139NEW HAVEN, Conn., May 12 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Findit-5/12/2003
138Here is the link to GNSC's collaborators genaissance.com And here is PerlegMike McFarland-5/9/2003
137Parking form the 10K... OUR COLLABORATIONS Through December 31, 2002, we hnigel bates-4/29/2003
136Yale University and Genaissance Pharmaceuticals Co-Sponsor Conference on Pharmacnigel bates-4/16/2003
135NEW HAVEN, Conn., and FREMONT, Calif., April 1 /PRNewswire-FirstCall/ -- Genaissnigel bates-4/1/2003
134NEW HAVEN, Conn., March 25 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticalsnigel bates-3/25/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News